Charging Robotics Israel sells 51% stake to Clearmind for $2.5 million

• Charging Robotics’ Israeli unit sold 51% to Clearmind Medicine via 149 newly issued ordinary shares for USD 2.5 million cash.
• Clearmind also funded a USD 1.5 million loan to the unit, carrying 4% annual interest with a three-year maturity.
• Charging Robotics kept a 49% stake, lost control of the unit, deconsolidated it, then shifted to equity-method accounting.
• Pro forma filings show a USD 4.87 million gain on deconsolidation, based on the fair value of the retained interest.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Charging Robotics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-097409), on September 04, 2026, and is solely responsible for the information contained therein.